We are live on ! Find out more
CI

Chartist Inc Portfolio holdings

AUM $139M
This Fund
S&P 500
This Quarter Est. Return
-0.58%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$207M
AUM Growth
-$3.62M
Cap. Flow
+$12.8M
Cap. Flow %
6.16%
Top 10 Hldgs %
61.4%
Holding
42
New
1
Increased
4
Reduced
23
Closed
3

Sector Composition

Rank Sector Weight
1 Materials 21.13%
2 Consumer Discretionary 6.12%
3 Communication Services 4.83%
4 Financials 3.22%
5 Healthcare 2.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TJX icon
26
TJX Companies
TJX
$172B
$2.02M 0.98%
60,660
PHM icon
27
Pultegroup
PHM
$23.5B
$2.01M 0.97%
98,818
-258
-0.3% -$5.23K
TFCFA
28
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$1.99M 0.96%
60,497
+1
+0% +$34
STI
29
DELISTED
SunTrust Banks, Inc.
STI
$1.98M 0.96%
45,388
+1
+0% +$43
BUD icon
30
AB InBev
BUD
$156B
$1.98M 0.95%
16,141
TGT icon
31
Target
TGT
$63.4B
$1.69M 0.81%
20,408
EBAY icon
32
eBay
EBAY
$50.7B
$1.63M 0.79%
64,596
DHI icon
33
D.R. Horton
DHI
$41.1B
$1.56M 0.75%
57,045
CPRI icon
34
Capri Holdings
CPRI
$1.83B
$845K 0.41%
19,673
-223
-1% -$12.6K
AXDX
35
DELISTED
Accelerate Diagnostics
AXDX
$561K 0.27%
2,193
JPC icon
36
Nuveen Preferred & Income Opportunities Fund
JPC
$2.93B
$280K 0.14%
12,500
-3,500
-22% -$33.4K
GHY
37
PGIM Global High Yield Fund
GHY
$489M
$212K 0.1%
14,000
-2,000
-13% -$31.5K
NWSA
38
DELISTED
NEWS CORPORATION CL-A
NWSA
$202K 0.1%
13,756
-95
-0.7% -$1.4K
ISD
39
PGIM High Yield Bond Fund
ISD
$425M
-13,000
Closed -$212K
AGN
40
DELISTED
Allergan plc
AGN
-15,248
Closed -$4.49M

Similar funds

Chartist Inc's Q2 2015 Portfolio in Review

As of Q2 2015, Chartist Inc held 42 positions worth $207M, down 1.7% from $211M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Chartist Inc deployed $12.8M of net new capital in Q2 2015, opening 1 new position and adding to 4 existing holdings. Its largest new stake was Allergan Inc: 15,248 shares worth $4.69M.

By sector, the portfolio is most concentrated in Materials at 21% of assets, up from 1.4% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was iShares Biotechnology ETF, an estimated $244K trimmed.

  • Chartist Inc's largest Q2 2015 buy was Allergan Inc: 15,248 shares worth $4.69M.
  • Chartist Inc added most to Sherwin-Williams in Q2 2015, an estimated $56.2M increase.
  • Chartist Inc's biggest Q2 2015 reduction was iShares Biotechnology ETF, cutting an estimated $244K.
  • Chartist Inc fully exited Allergan plc in Q2 2015, selling an estimated $4.49M.
  • Chartist Inc's ten largest holdings make up 61% of its $207M portfolio in Q2 2015.
  • Chartist Inc opened 1 new position and closed 3 in Q2 2015.
  • Chartist Inc's portfolio value fell 1.7% quarter-over-quarter to $207M.

Based on Chartist Inc's 13F filing for Q2 2015, filed 17 Jul 2015.